Company / Operating Income per Share
IONIS PHARMACEUTICALS INC Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$2.42
FY2025
5-year range
-$3.29 / $2.61
FY2021-FY2025
Trend
+26.6%
vs FY2024
Sector context
#126 of 201
Health Care
What the data says
At $-2.42, IONIS PHARMACEUTICALS INC's operating income per share ranks #126 of 201 in the Health Care sector. Operating Income per Share has fluctuated over the past 10 years, ranging from $-3.29 in FY2024 to $2.61 in FY2021.
Based on SEC 10-K filings.
-2.42 in FY2025.
Improved from $-2.49 to $-2.42 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#126 of 201 in Health CareTop 63% of 201This company -$2.42 Sector average -$3.23
▼
+25.2% above sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 26.6% year-over-year.
- Ranks #126 out of 201 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2021.
- Lowest operating income per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.42 | +26.6% |
| FY2024 | -$3.29 | -32.2% |
| FY2023 | -$2.49 | +14.3% |
| FY2022 | -$2.90 | -211.4% |
| FY2021 | $2.61 | +696.1% |
| FY2020 | -$0.44 | -294.3% |
| FY2019 | $0.23 | +239.5% |
| FY2018 | -$0.16 | -163.2% |
| FY2017 | $0.26 | +252.4% |
| FY2016 | -$0.17 | +73.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026